BRPI1008537A2 - lactobacillus rharmnosus ncc4007, mistura probiótica e controle de peso - Google Patents

lactobacillus rharmnosus ncc4007, mistura probiótica e controle de peso

Info

Publication number
BRPI1008537A2
BRPI1008537A2 BRPI1008537A BRPI1008537A BRPI1008537A2 BR PI1008537 A2 BRPI1008537 A2 BR PI1008537A2 BR PI1008537 A BRPI1008537 A BR PI1008537A BR PI1008537 A BRPI1008537 A BR PI1008537A BR PI1008537 A2 BRPI1008537 A2 BR PI1008537A2
Authority
BR
Brazil
Prior art keywords
rharmnosus
ncc4007
lactobacillus
weight control
probiotic mixture
Prior art date
Application number
BRPI1008537A
Other languages
English (en)
Inventor
Catherine Mace
Christian Darimont-Nicolau
David Philippe
Fabrizio Arigoni
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI1008537A2 publication Critical patent/BRPI1008537A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
BRPI1008537A 2009-02-10 2010-02-04 lactobacillus rharmnosus ncc4007, mistura probiótica e controle de peso BRPI1008537A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09152437A EP2216036A1 (en) 2009-02-10 2009-02-10 Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
PCT/EP2010/051362 WO2010091992A1 (en) 2009-02-10 2010-02-04 Lactobacillus rhamnosus ncc4007, a probiotic mixture and weight control

Publications (1)

Publication Number Publication Date
BRPI1008537A2 true BRPI1008537A2 (pt) 2016-03-15

Family

ID=40758983

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008537A BRPI1008537A2 (pt) 2009-02-10 2010-02-04 lactobacillus rharmnosus ncc4007, mistura probiótica e controle de peso

Country Status (8)

Country Link
US (1) US8318151B2 (pt)
EP (2) EP2216036A1 (pt)
CN (1) CN102316880B (pt)
AU (1) AU2010213009B2 (pt)
BR (1) BRPI1008537A2 (pt)
CL (1) CL2011001940A1 (pt)
MX (1) MX2011008399A (pt)
WO (1) WO2010091992A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2453591C1 (ru) * 2011-04-21 2012-06-20 Общество с ограниченной ответственностью "Бифилюкс" Штамм lactobacillus rhamnosus, используемый для получения продукции, содержащей лактобактерии
US9308271B2 (en) 2011-06-30 2016-04-12 Chr. Hansen A/S Compositions
ITMI20111488A1 (it) 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
WO2014058301A1 (en) 2012-10-12 2014-04-17 N.V. Nutricia Infant nutrition with lipid globules to increase energy expenditure and metabolic flexibility later in life
JP2016501010A (ja) * 2012-11-12 2016-01-18 コンパニ・ジェルベ・ダノンＣｏｍｐａｇｎｉｅ Ｇｅｒｖａｉｓ Ｄａｎｏｎｅ 体重増加及び／又はインスリン抵抗性を低減させるためのラクトバチルスラムノサス株の使用
WO2015061135A1 (en) * 2013-10-24 2015-04-30 Danisco Us Inc. Functional oligosaccharides composition and a method for reducing fermentable sugars
TR201816481T4 (tr) 2013-11-01 2018-11-21 Nutricia Nv Yakalama büyümesi sırasında vücut bileşimini geliştirmek için lipit bileşimler.
GB201319538D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition
GB201319540D0 (en) 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition
GB201319531D0 (en) 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition & methods of screening
GB201319539D0 (en) 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition & methods of screening
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
KR102125548B1 (ko) 2015-02-10 2020-06-24 주식회사 지니스 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물
JP6837015B2 (ja) * 2015-06-29 2021-03-03 フェリング ベスローテン フェンノートシャップ たとえば、細菌性膣炎の治療のためのＬａｃｔｏｂａｃｉｌｌｕｓ ｒｈａｍｎｏｓｕｓ（ラクトバチルス・ラムノサス）細菌
EP3361885B1 (en) 2015-10-15 2019-05-29 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
CN106754470A (zh) * 2016-11-11 2017-05-31 中国农业科学院饲料研究所 一株人母乳来源的鼠李糖乳杆菌及其应用
US20240180860A1 (en) 2016-12-09 2024-06-06 N.V. Nutricia Nutritional composition for improving cell membranes
CN107475162B (zh) * 2017-09-25 2020-10-23 中国农业科学院农产品加工研究所 具有二肽基肽酶-iv高抑制活性的鼠李糖乳杆菌及其应用
PT3716958T (pt) 2017-11-28 2023-12-07 Dermapharm Ag Composição para o tratamento de disbiose da microbiota intestinal
CA3088630A1 (en) 2017-12-15 2019-06-20 Solarea Bio, Inc. Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome
BE1025428B1 (nl) * 2018-01-23 2019-02-14 Omega Pharma Innovation & Development Nv Voedingssupplement en gebruiken daarvan
WO2020051379A1 (en) 2018-09-05 2020-03-12 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases
US11980647B2 (en) 2018-09-05 2024-05-14 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
CN109757730B (zh) * 2019-01-31 2021-06-04 山东环亿生物科技有限公司 一种具有降血脂、血压以及血糖的组合物及其制备方法
WO2022167134A1 (en) 2021-02-04 2022-08-11 Société des Produits Nestlé S.A. Plant-based products fermented with b. amyloliquefaciens and p. freudenreichii having increased vit b12 content
AU2022391767A1 (en) 2021-11-22 2024-07-04 Solarea Bio, Inc. Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause
US20230190834A1 (en) 2021-12-21 2023-06-22 Solarea Bio, Inc. Immunomodulatory compositions comprising microbial entities

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040161422A1 (en) * 1999-04-30 2004-08-19 Natarajan Ranganathan Nutritional compositions comprising probiotics
IL137635A0 (en) * 2000-08-01 2001-10-31 Visionix Ltd Apparatus for interactive optometry
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
NO320546B1 (no) * 2003-12-12 2005-12-19 Nova Biotics As Prebiotiske kombinasjonsprodukter
US7001756B1 (en) 2004-02-19 2006-02-21 Genmont Biotech Inc. Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity
CN100396770C (zh) 2004-03-19 2008-06-25 景岳生物科技股份有限公司 新的微生物鼠李糖乳杆菌gm-020及其治疗肥胖的用途
KR100686557B1 (ko) 2004-08-16 2007-02-23 씨제이 주식회사 체지방 저하 기능성 락토바실러스 람노서스와 이를 함유한 식품
MX2007012697A (es) * 2005-04-13 2008-01-14 Nestec Sa Formula para infantes con probioticos.
EP1886680A1 (en) * 2006-05-23 2008-02-13 Nestec S.A. Maternal supplement
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity

Also Published As

Publication number Publication date
AU2010213009B2 (en) 2014-07-10
EP2396014A1 (en) 2011-12-21
US20120039852A1 (en) 2012-02-16
AU2010213009A1 (en) 2011-08-25
WO2010091992A1 (en) 2010-08-19
CL2011001940A1 (es) 2012-01-20
US8318151B2 (en) 2012-11-27
CN102316880B (zh) 2013-08-07
EP2216036A1 (en) 2010-08-11
MX2011008399A (es) 2011-09-01
CN102316880A (zh) 2012-01-11

Similar Documents

Publication Publication Date Title
BRPI1008537A2 (pt) lactobacillus rharmnosus ncc4007, mistura probiótica e controle de peso
HK1258140A1 (zh) 經修飾鬆弛素多肽及其用途
IL260045B (en) Polypeptide structures and their uses
BRPI0814934A2 (pt) Lactobacillus rhammosus e controle de peso
HK1211961A1 (en) Anti-vegf antibodies and their uses vegf
IL225484A0 (en) Anti-48cd antibodies and their uses
BRPI0815506A2 (pt) Flora intestinal e controle de peso
HK1186351A1 (en) Stevia composition with reduced or eliminated aftertaste of stevia
BRPI1008355A2 (pt) lactobacillus helveticus cncm i-4095 e controle de peso
HK1212165A1 (en) Nutritional compositions including calcium beta-hydroxy-beta- methylbutyrate, protein and low levels of electrolytes ---
EP2558571A4 (en) DELAYED POLYPEPTIDE EXPRESSION FROM MODIFIED SYNTHETIC RNAS AND USES THEREOF
BR112012004571A2 (pt) bolsa para o preparo de uma bebida
EP2593469A4 (en) MODIFIED PROTEINS AND POLYPEPTIDES AND USES THEREOF
EP3082450A4 (en) Pet food composition having probiotic bifidobacterium animalis
BRPI1008327A2 (pt) lactobacillus rhamnosus cncm i-4096 e controle de peso
EP2554858A4 (en) CONNECTING BAR AND DOUBLE-SIDED CHANGING MECANISM FOR THIS
DE112010003281A5 (de) Zusammensetzung mit stämmen von lactobazillus fermentum
GB201301133D0 (en) Inflatable packer and control valve
BR112012003860A2 (pt) Combinação, e, composição nutricional
GB201007115D0 (en) Sea lice control
EP2633082A4 (en) QUICK SERROTYPAGE ASSAY OF SALMONELLA
ZA201304214B (en) Lactone compounds and materials made therefrom
EP2570409A4 (en) ARALKYL DIAMINE DERIVATIVES AND THEIR USE AS ANTIDEPRESSIVA
IL227621A0 (en) Oxygen sensors and their use
GB201006188D0 (en) Oxidzed egg protiens and uses thereof

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2447 DE 28-11-2017 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 35/747 (2015.01), A23K 10/18 (2016.01), A23K